DrugsControl Media Services

News Detail

US FDA flags data manipulation, management failures in warning letter to Intas on import alert (01-12-2023)

Maryland, 30 Nov 2023: Drug manufacturer Intas Pharmaceuticals is no stranger to FDA scrutiny. Now, one of its plants has been placed on an import alert after a series of interactions with the agency.

View Details

Source : Fierce Pharma
Intas FDA warning letter import alert Fierce Pharma Homepage Manufacturing

Related News